APPLIED GENETIC TECHNOLOGIES CORP Share-based Payment Arrangement, Expense
APPLIED GENETIC TECHNOLOGIES CORP reported Share-based Payment Arrangement, Expense of $3.42 million for the 12-month period ending 2022-06-30, per its 10-K filed 2022-09-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-09-27
- APPLIED GENETIC TECHNOLOGIES CORP share-based payment arrangement, expense for the quarter ending 2017-12-31 was $1.30M.
- APPLIED GENETIC TECHNOLOGIES CORP share-based payment arrangement, expense for fiscal 2022 was $3.42M, a 27.89% increase from fiscal 2021.
- APPLIED GENETIC TECHNOLOGIES CORP share-based payment arrangement, expense for fiscal 2021 was $2.68M, a 10.67% decline from fiscal 2020.
- APPLIED GENETIC TECHNOLOGIES CORP share-based payment arrangement, expense for fiscal 2020 was $3.00M, a 25.59% decline from fiscal 2019.
- APPLIED GENETIC TECHNOLOGIES CORP share-based payment arrangement, expense for fiscal 2019 was $4.03M, a 22.41% decline from fiscal 2018.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|
| 2022-06-30 | $3.42M 10-K · filed 2022-09-27 | ||
| 2021-06-30 | $2.68M 10-K · filed 2022-09-27 | ||
| 2020-06-30 | $3.00M 10-K · filed 2021-09-23 | ||
| 2019-06-30 | $4.03M 10-K · filed 2020-09-18 | ||
| 2018-06-30 | $5.19M 10-K · filed 2019-09-26 | ||
| 2017-12-31 | $1.30M 10-Q · filed 2019-02-07 | $2.80M 10-Q · filed 2019-02-07 | |
| 2017-06-30 | $5.61M 10-K · filed 2018-09-11 | ||
| 2016-06-30 | $5.01M 10-K · filed 2018-09-11 | ||
| 2015-06-30 | $2.82M 10-K · filed 2017-09-13 | ||
| 2014-06-30 | $825.00K 10-K/A · filed 2017-09-08 |